Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

mRNA Therapeutics Market Size to Surpass USD 78.09 Billion by 2035 Caused by the Increasing Investment in Genetic Medicine Research Globally | SNS Insider

globenewswire.com
PFE Pfizer's mRNA vaccine success is highlighted as a key driver for the mRNA therapeutics market growth, indicating strong market position and future potential. MRNA Moderna's mRNA vaccine success is cited as a major factor contributing to the growth of the mRNA therapeutics market, suggesting a positive outlook for the company.

mRNA Therapeutics Market Size to Surpass USD 78.09 Billion by 2035 Caused by the Increasing Investment in Genetic Medicine Research Globally | SNS Insider Austin, March 11, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The mRNA Therapeutics Market size is estimated at USD 16.19 billion in 2025 and is expected to reach USD 78.09 billion by 2035, growing at a CAGR of 17.04% over 2026-2035.

The global mRNA therapeutics market is experiencing strong growth due to rising demand for advanced vaccine technologies such as lipid nanoparticle delivery systems, self-amplifying RNA platforms, and personalized cancer immunotherapies. Increased investments in genetic medicine research, rapid vaccine development capabilities, and improvements in mRNA stability and delivery systems are further driving the market. Additionally, the growing adoption of precision medicine and a stronger focus on rare disease treatments are encouraging pharmaceutical companies to develop targeted mRNA-based therapies, boosting both domestic and international demand for innovative vaccines and therapeutic solutions.

mRNA Therapeutics Market Size and Forecast:

Instantly Access the Sample Report of mRNA Therapeutics Market Forecast @ https://www.snsinsider.com/sample-request/2671

The U.S. mRNA Therapeutics Market is estimated at USD 6.85 billion in 2025 and is expected to reach USD 33.04 billion by 2035, growing at a CAGR of 17.23% from 2026-2035.

The U.S. represents the largest market for mRNA therapeutics, primarily driven by the extensive biotechnology infrastructure, federal funding for genetic medicine research, and well-developed clinical trial networks.

Breakthrough Success of COVID-19 mRNA Vaccines Drive Market Growth Globally

The proven efficacy and safety profiles of Pfizer-BioNTech and Moderna vaccines, quick development times, and widespread regulatory acceptance of mRNA technology platforms are the main factors driving the breakthrough success of COVID-19 mRNA vaccines as a growth driver for the mRNA therapeutics market share. These therapeutic intervention and preventive strategies for infectious diseases are driving the market's base, penetrating the markets for therapeutic drugs and preventative vaccines, and increasing the market's overall share worldwide.

mRNA Therapeutics Market Segmentation Analysis:

By Type

The prophylactic vaccines segment accounted for the highest revenue share of approximately 67.42% in 2025, owing to widespread COVID-19 vaccine deployment and established regulatory pathways for infectious disease prevention. The therapeutic drugs segment is anticipated to achieve the highest CAGR of nearly 18.35% during the 2026–2035 period, driven by the expanding oncology pipeline and breakthrough therapy designations for rare diseases globally.

By Application

By 2025, the infectious disease segment contributed the largest revenue share of 59.28% due to established COVID-19 vaccine market, ongoing pandemic preparedness initiatives and continued development of vaccines for emerging pathogens. The rare genetic disease segment is projected to grow at the highest CAGR of about 19.12% between 2026 and 2035 due to the growing need for novel treatments for previously undruggable genetic disorders and enzyme deficiency syndromes.

By End-User

The hospitals and clinics segment accounted for the largest share of the mRNA therapeutics market with about 64.17%, owing to their direct patient care responsibilities globally. The research organizations are slated to grow at the fastest rate with a CAGR of around 17.89% throughout the forecast period of 2026–2035, as academic institutions, biotechnology companies, and pharmaceutical research centers seek advanced mRNA discovery platforms globally.

Get Expert-Led Insights for Your Business Strategy — Connect with Analysts Now @ https://www.snsinsider.com/request-analyst/2671

mRNA Therapeutics Market Regional Insights:

North America held the largest revenue share of over 42.34% in 2025 of the mRNA therapeutics market due to an established biotechnology ecosystem, pioneering vaccine development success, and increased venture capital funding for genetic medicine startups.

Asia Pacific is the fastest-growing segment in the mRNA therapeutics market with a CAGR of 18.76%, as the awareness about genetic medicine capabilities, government investment in biotechnology infrastructure, and pharmaceutical manufacturing expansion in developing nations is growing.

Major Players Analysis Listed in the mRNA Therapeutics Market Report:

mRNA Therapeutics Market Recent Developments:

Purchase Single User PDF of mRNA Therapeutics Market Intelligence Report @ https://www.snsinsider.com/checkout/2671

Exclusive Sections of the Report (The USPs):

mRNA Therapeutics Market Report Scope

Demand for Industry Analysis: Our Comprehensive Report mRNA Therapeutics Market @ https://www.snsinsider.com/reports/mrna-therapeutics-market-2671

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.